/People

Jorge Conde

Investor

Investing at Andreessen Horowitz

Menlo Park, California

Writes $1M – $100M checks · typically $10M

Find your path to Jorge

Sign up to see every warm intro you have to Jorge

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Jorge. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Jorge Conde co-founded a synthetic biology company with genomics pioneer George Church at Harvard before entering venture capital and regularly hosts podcasts interviewing scientists and CEOs, bridging academia and entrepreneurship.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechConsumerCrypto & Web3Defense Tech

Beyond investing

Founded
Jorge Conde cofounded Knome, a human genome interpretation company acquired by Tute Genomics in 2015.
Education
Studied at Harvard Business School (MBA) Studied at Harvard-MIT Division of Health Sciences and Technology (MS) Studied at Johns Hopkins University (BA, biology)
Boards
Jorge Conde previously served on the board of the Museum of Science, Boston.
Communities
Jorge Conde is a member of the Aspen Global Leadership Network.
Awards
Jorge Conde was named one of the top 35 young innovators in the world by the MIT Technology Review. Jorge Conde is a Henry Crown Fellow of the Aspen Institute.
Hobbies
Jorge Conde and his family cheer for Real Madrid, the Boston Red Sox, and the Miami Dolphins.
Family
Jorge Conde was born and raised in Miami by Cuban and Peruvian parents, is married to a Madrileña, and lives in California with his family.

From published sources — common ground for a warm intro.

Deals · 2

EarliBoard seat

via Andreessen Horowitz · filed Jan 2021 · $40M raise

Camp4 Therapeutics CorpBoard seat

via Andreessen Horowitz · filed Sep 2018 · $34.1M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: curated public sources · SEC Form D filings.

Colleagues at Andreessen Horowitz

Network1

Investors connected to Jorge in public investor directories — a warm-intro map.

Frequently asked questions

Who is Jorge Conde?
Jorge Conde co-founded a synthetic biology company with genomics pioneer George Church at Harvard before entering venture capital and regularly hosts podcasts interviewing scientists and CEOs, bridging academia and entrepreneurship.
Where does Jorge Conde work?
Jorge Conde is Investing at Andreessen Horowitz.
What does Jorge Conde invest in?
Jorge Conde invests in AI & Machine Learning, Biotech, Consumer, Crypto & Web3, Defense Tech.
What check size does Jorge Conde write?
Jorge Conde typically writes checks of $1M – $100M.
What boards does Jorge Conde sit on?
Jorge Conde holds tracked board seats at Asimov, Camp4, Camp4 Therapeutics Corp, Cartography, Dyno, Earli, Earli, EQRx, IDRx, Komodo Health.
What companies has Jorge Conde invested in?
Investments tracked here include Camp4 Therapeutics Corp, Asimov, Cartography Biosciences, Dyno Therapeutics, Earli, EQRx, Erasca, FidoCure, Komodo Health, Octant Bio, Phylo, Third Arc Bio, and 3 more.
What awards has Jorge Conde received?
Jorge Conde was named one of the top 35 young innovators in the world by the MIT Technology Review. Jorge Conde is a Henry Crown Fellow of the Aspen Institute.
Does Jorge Conde lead rounds?
Yes — Jorge Conde has led 1 tracked investment.

About this profile. Compiled from public sources — Andreessen Horowitz's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights